|
Jul 29
|
Therma Bright's Venowave VW5 Secures FDA 510K Approval
|
|
Jun 21
|
Therma Bright Closes Second & Final Tranche of Fully Subscribed Non-Brokered Private Placement
|
|
Jun 19
|
Therma Bright Completes Debt Settlements
|
|
Nov 29
|
Therma Bright Prepares FDA 513(g) Review Document for its AI-Driven Digital Cough Analyzer (DCA)
|
|
Oct 25
|
TSX Venture Exchange Stock Maintenance Bulletins
|
|
Aug 7
|
Therma Bright CEO says permanent insurance codes for Venowave could be a game changer
|